VRTX | | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | Apr 01, 2024 | Option Exercise | $418.10 | 225 | 94,073 | 7,740 | Apr 03, 2024, 04:02 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | Apr 02, 2024 | Sale | $419.00 | 240 | 100,560 | 7,500 | Apr 03, 2024, 04:02 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Feb 23, 2024 | Option Exercise | $431.79 | 3,309 | 1,428,793 | 53,583 | Feb 27, 2024, 05:08 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 23, 2024 | Option Exercise | $431.79 | 3,309 | 1,428,793 | 56,158 | Feb 27, 2024, 05:02 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 26, 2024 | Sale | $425.70 | 354 | 150,698 | 55,804 | Feb 27, 2024, 05:02 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 23, 2024 | Option Exercise | $431.79 | 2,469 | 1,066,090 | 58,329 | Feb 27, 2024, 04:59 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 26, 2024 | Sale | $425.70 | 3,004 | 1,278,803 | 55,325 | Feb 27, 2024, 04:59 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 23, 2024 | Option Exercise | $431.79 | 9,386 | 4,052,781 | 136,507 | Feb 27, 2024, 04:55 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Feb 23, 2024 | Option Exercise | $431.79 | 3,309 | 1,428,793 | 36,939 | Feb 27, 2024, 04:50 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 23, 2024 | Option Exercise | $431.79 | 1,654 | 714,181 | 16,855 | Feb 27, 2024, 04:44 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 26, 2024 | Sale | $425.70 | 883 | 375,893 | 15,972 | Feb 27, 2024, 04:44 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 26, 2024 | Sale | $425.70 | 5,034 | 2,142,974 | 49,691 | Feb 27, 2024, 04:37 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 23, 2024 | Option Exercise | $431.79 | 4,714 | 2,035,458 | 54,725 | Feb 27, 2024, 04:37 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | Feb 26, 2024 | Sale | $425.70 | 883 | 375,893 | 7,965 | Feb 27, 2024, 04:29 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | Feb 23, 2024 | Option Exercise | $431.79 | 828 | 357,522 | 8,848 | Feb 27, 2024, 04:29 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 23, 2024 | Option Exercise | $431.79 | 3,970 | 1,714,206 | 30,052 | Feb 27, 2024, 04:24 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 26, 2024 | Sale | $425.70 | 4,239 | 1,804,542 | 25,813 | Feb 27, 2024, 04:24 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 21, 2024 | Sale | $421.77 | 360 | 151,837 | 59,467 | Feb 23, 2024, 04:28 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 21, 2024 | Sale | $421.77 | 3,191 | 1,345,868 | 60,798 | Feb 23, 2024, 04:20 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 21, 2024 | Sale | $421.77 | 1,201 | 506,546 | 18,509 | Feb 23, 2024, 04:16 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 21, 2024 | Sale | $421.77 | 3,603 | 1,519,637 | 59,439 | Feb 23, 2024, 04:12 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 21, 2024 | Sale | $421.77 | 3,002 | 1,266,154 | 34,022 | Feb 23, 2024, 04:10 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Feb 16, 2024 | Option Exercise | $424.01 | 3,750 | 1,590,038 | 59,704 | Feb 21, 2024, 04:49 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Feb 20, 2024 | Option Exercise | $420.58 | 2,812 | 1,182,671 | 56,892 | Feb 21, 2024, 04:49 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 16, 2024 | Option Exercise | $424.01 | 4,499 | 1,907,621 | 63,680 | Feb 21, 2024, 04:43 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 20, 2024 | Option Exercise | $420.61 | 3,853 | 1,620,595 | 60,307 | Feb 21, 2024, 04:43 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 16, 2024 | Option Exercise | $424.01 | 3,498 | 1,483,187 | 70,866 | Feb 21, 2024, 04:38 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 20, 2024 | Sale | $420.71 | 6,877 | 2,893,222 | 68,243 | Feb 21, 2024, 04:38 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | Feb 20, 2024 | Option Exercise | $420.58 | 4,118 | 1,731,948 | 13,778 | Feb 21, 2024, 04:34 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Feb 20, 2024 | Option Exercise | $420.58 | 2,812 | 1,182,671 | 40,248 | Feb 21, 2024, 04:26 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Feb 16, 2024 | Option Exercise | $424.01 | 3,750 | 1,590,038 | 43,060 | Feb 21, 2024, 04:26 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 16, 2024 | Option Exercise | $424.01 | 1,501 | 636,439 | 21,636 | Feb 21, 2024, 04:23 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 20, 2024 | Sale | $420.67 | 1,926 | 810,205 | 20,511 | Feb 21, 2024, 04:23 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 20, 2024 | Option Exercise | $420.70 | 8,177 | 3,440,091 | 67,846 | Feb 21, 2024, 04:19 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 16, 2024 | Option Exercise | $424.01 | 4,499 | 1,907,621 | 71,219 | Feb 21, 2024, 04:19 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 16, 2024 | Option Exercise | $424.01 | 3,750 | 1,590,038 | 43,838 | Feb 21, 2024, 04:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 20, 2024 | Option Exercise | $420.70 | 6,814 | 2,866,673 | 41,026 | Feb 21, 2024, 04:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | Feb 14, 2024 | Sale | $419.04 | 4,356 | 1,825,338 | 22,551 | Feb 16, 2024, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | Feb 15, 2024 | Sale | $419.16 | 4,655 | 1,951,190 | 17,896 | Feb 16, 2024, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | Feb 13, 2024 | Sale | $419.13 | 737 | 308,899 | 26,907 | Feb 14, 2024, 04:04 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | Feb 12, 2024 | Sale | $419.51 | 2,656 | 1,114,205 | 28,291 | Feb 14, 2024, 04:04 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Feb 09, 2024 | Option Exercise | $422.74 | 2,607 | 1,102,083 | 63,454 | Feb 13, 2024, 05:34 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 09, 2024 | Option Exercise | $422.74 | 2,100 | 887,754 | 68,493 | Feb 13, 2024, 05:23 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Feb 12, 2024 | Sale | $420.24 | 314 | 131,955 | 68,179 | Feb 13, 2024, 05:23 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 09, 2024 | Option Exercise | $422.74 | 2,022 | 854,780 | 77,586 | Feb 13, 2024, 05:15 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Feb 12, 2024 | Sale | $420.24 | 3,222 | 1,354,013 | 74,364 | Feb 13, 2024, 05:15 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Feb 09, 2024 | Option Exercise | $422.74 | 8,255 | 3,489,719 | 162,271 | Feb 13, 2024, 05:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Feb 09, 2024 | Option Exercise | $422.74 | 2,100 | 887,754 | 46,810 | Feb 13, 2024, 05:01 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Biller Jonathan | EVP and Chief Legal Officer | Feb 09, 2024 | Option Exercise | $422.74 | 1,588 | 671,311 | 20,018 | Feb 13, 2024, 04:56 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Biller Jonathan | EVP and Chief Legal Officer | Feb 12, 2024 | Sale | $418.77 | 1,738 | 727,822 | 18,280 | Feb 13, 2024, 04:56 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 09, 2024 | Option Exercise | $422.74 | 832 | 351,720 | 24,050 | Feb 13, 2024, 04:54 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Feb 12, 2024 | Sale | $420.24 | 913 | 383,679 | 23,137 | Feb 13, 2024, 04:54 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 09, 2024 | Option Exercise | $422.74 | 3,177 | 1,343,045 | 80,013 | Feb 13, 2024, 04:51 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Feb 12, 2024 | Sale | $420.24 | 4,295 | 1,804,931 | 75,718 | Feb 13, 2024, 04:51 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | Feb 09, 2024 | Option Exercise | $422.74 | 591 | 249,839 | 11,050 | Feb 13, 2024, 04:48 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | Feb 12, 2024 | Sale | $420.24 | 1,374 | 577,410 | 9,676 | Feb 13, 2024, 04:48 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 09, 2024 | Option Exercise | $422.74 | 2,099 | 887,331 | 50,733 | Feb 13, 2024, 04:46 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Feb 12, 2024 | Sale | $420.24 | 3,145 | 1,321,655 | 47,588 | Feb 13, 2024, 04:46 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | Feb 08, 2024 | Option Exercise | $421.73 | 2,698 | 1,137,828 | 38,348 | Feb 12, 2024, 04:08 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | Feb 09, 2024 | Option Exercise | $422.74 | 8,048 | 3,402,211 | 30,300 | Feb 12, 2024, 04:08 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | Jan 08, 2024 | Sale | $419.07 | 6,648 | 2,785,977 | 2,423 | Jan 10, 2024, 04:06 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Dec 15, 2023 | Sale | $294.41 | 34,270 | 10,089,538 | 125,846 | Dec 19, 2023, 04:15 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | Dec 13, 2023 | Sale | $399.42 | 13,354 | 5,333,799 | 9,171 | Dec 15, 2023, 04:33 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Dec 13, 2023 | Sale | $397.00 | 5,098 | 2,023,906 | 108,711 | Dec 15, 2023, 04:23 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Dec 13, 2023 | Option Exercise | $293.26 | 17,206 | 5,045,918 | 65,159 | Dec 15, 2023, 04:20 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | WAGNER CHARLES F JR | EVP & Chief Financial Officer | Nov 20, 2023 | Sale | $349.88 | 3,000 | 1,049,640 | 46,693 | Nov 21, 2023, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP Chief Patient & Ext Af Off | Nov 15, 2023 | Sale | $369.92 | 35 | 12,947 | 58,814 | Nov 17, 2023, 04:16 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Nov 15, 2023 | Sale | $369.92 | 19 | 7,028 | 32,038 | Nov 17, 2023, 04:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Nov 14, 2023 | Sale | $380.82 | 5,650 | 2,151,633 | 29,302 | Nov 16, 2023, 04:15 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Nov 13, 2023 | Sale | $377.00 | 5,097 | 1,921,569 | 113,809 | Nov 15, 2023, 04:16 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Director | Nov 06, 2023 | Sale | $256.27 | 22,500 | 5,766,075 | 51,250 | Nov 08, 2023, 04:11 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Oct 31, 2023 | Sale | $355.92 | 5,651 | 2,011,304 | 34,952 | Nov 02, 2023, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Oct 17, 2023 | Sale | $373.25 | 5,651 | 2,109,236 | 40,603 | Oct 19, 2023, 04:18 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bhatia Sangeeta N. | Director | Oct 17, 2023 | Sale | $375.00 | 243 | 91,125 | 3,901 | Oct 19, 2023, 04:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | Oct 16, 2023 | Sale | $374.00 | 12,962 | 4,847,788 | 22,425 | Oct 18, 2023, 04:17 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bhatia Sangeeta N. | Director | Oct 06, 2023 | Sale | $360.00 | 242 | 87,120 | 4,144 | Oct 11, 2023, 04:14 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Oct 03, 2023 | Sale | $345.28 | 5,651 | 1,951,177 | 46,254 | Oct 05, 2023, 04:30 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sep 19, 2023 | Sale | $351.00 | 5,651 | 1,983,501 | 51,905 | Sep 21, 2023, 04:15 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bozic Carmen | EVP and CMO | Sep 05, 2023 | Sale | $352.66 | 5,651 | 1,992,882 | 57,556 | Sep 07, 2023, 04:29 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Aug 23, 2023 | Sale | $355.00 | 2,500 | 887,500 | 48,637 | Aug 25, 2023, 04:14 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Kearney Terrence C | Director | Aug 10, 2023 | Sale | $238.77 | 20,000 | 4,775,400 | 16,536 | Aug 14, 2023, 04:09 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Aug 10, 2023 | Sale | $345.79 | 5,750 | 1,988,293 | 51,137 | Aug 14, 2023, 04:08 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sachdev Amit | EVP, Chief Patient Officer | Aug 10, 2023 | Sale | $350.00 | 10,031 | 3,510,850 | 58,814 | Aug 14, 2023, 04:05 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | ALTSHULER DAVID | EVP, Global Research and CSO | Aug 09, 2023 | Sale | $345.51 | 63 | 21,767 | 32,038 | Aug 11, 2023, 04:05 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bhatia Sangeeta N. | Director | Aug 09, 2023 | Sale | $345.51 | 242 | 83,613 | 4,386 | Aug 11, 2023, 04:05 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | SACHS BRUCE I | Director | Jul 17, 2023 | Sale | $242.15 | 22,500 | 5,448,284 | 51,250 | Jul 18, 2023, 04:17 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Jul 17, 2023 | Sale | $355.00 | 7,828 | 2,778,940 | 118,906 | Jul 18, 2023, 04:13 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | Jun 15, 2023 | Option Exercise | $268.26 | 17,206 | 4,615,768 | 65,159 | Jun 20, 2023, 04:07 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Arbuckle Stuart A | EVP, COO | May 30, 2023 | Sale | $329.82 | 82 | 27,045 | 56,556 | Jun 01, 2023, 04:16 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Ambrose Kristen | SVP & Chief Accounting Officer | May 30, 2023 | Sale | $329.82 | 289 | 95,318 | 6,838 | Jun 01, 2023, 04:12 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | May 05, 2023 | Sale | $350.03 | 422 | 147,713 | 34,888 | May 09, 2023, 04:15 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | May 08, 2023 | Sale | $350.00 | 2,850 | 997,500 | 32,038 | May 09, 2023, 04:15 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | May 05, 2023 | Sale | $349.56 | 879 | 307,262 | 36,683 | May 09, 2023, 04:10 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | May 08, 2023 | Sale | $349.00 | 1,125 | 392,625 | 35,387 | May 09, 2023, 04:10 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | May 02, 2023 | Sale | $350.66 | 1,622 | 568,768 | 38,302 | May 04, 2023, 04:51 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Sanna Bastiano | EVP, Cell & Genetic Therapies | May 03, 2023 | Sale | $350.74 | 2,781 | 975,418 | 36,038 | May 04, 2023, 04:51 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | May 02, 2023 | Sale | $349.89 | 6,450 | 2,256,761 | 43,704 | May 04, 2023, 04:50 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | LEIDEN JEFFREY M | Executive Chairman | May 03, 2023 | Sale | $350.11 | 4,508 | 1,578,301 | 39,891 | May 04, 2023, 04:50 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Bhatia Sangeeta N. | Director | May 02, 2023 | Sale | $348.28 | 580 | 202,004 | 5,146 | May 03, 2023, 04:44 PM |
VRTX | | VERTEX PHARMACEUTICALS INC / MA | Kewalramani Reshma | CEO & President | Apr 27, 2023 | Sale | $339.08 | 3,317 | 1,124,726 | 128,358 | May 01, 2023, 04:26 PM |